InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-37.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by GOTTO ANTONIO M JR MD D PHIL, Director. Insider active across 1 company, notably Esperion Therapeutics, Inc.. In total, 4 disclosures have been published. Activity tracked since 27 May 2021. The latest transaction was filed on 23 May 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations4 total
23,000 shares0Common StockSEC:0001628280-24-025217:0
5,150 shares0Common StockSEC:0001628280-23-022450:0
12,376 shares0Common StockSEC:0001628280-21-011358:0
12,376 shares0Common StockSEC:0001628280-21-011358
4 of 4 declarations
About GOTTO ANTONIO M JR MD D PHIL
Antonio M. Gotto Jr, MD D Phil is a Director at Esperion Therapeutics, Inc. In this role, he participates in the governance and oversight of the company's activities. Esperion is a biopharmaceutical company. Antonio brings expertise in research and development as well as corporate strategy.
